Call for better response evaluation after neoadjuvant therapy in pancreatic cancer
Br J Surg
.
2023 Feb 15;110(3):294-296.
doi: 10.1093/bjs/znac452.
Authors
Claudia Zaharia
1
2
,
Kjetil Søreide
2
3
4
Affiliations
1
Department of Pathology, Stavanger University Hospital, Stavanger, Norway.
2
Gastrointestinal and Translational Research Group, Stavanger University Hospital, Stavanger, Norway.
3
Department of Gastrointestinal Surgery, Hepatopancreatobiliary Unit, Stavanger University Hospital, Stavanger, Norway.
4
Department of Clinical medicine, University of Bergen, Bergen, Norway.
PMID:
36630676
PMCID:
PMC10364493
DOI:
10.1093/bjs/znac452
No abstract available
MeSH terms
Antineoplastic Combined Chemotherapy Protocols
Humans
Neoadjuvant Therapy*
Pancreatectomy
Pancreatic Neoplasms* / drug therapy
Pancreatic Neoplasms* / surgery